Another study discussed various aptamer-based microfluidics systems for detecting ovarian cancer via targeting biomarkers such as CA-125 and CEA and ovarian cancer cells (Vandghanooni et al., 2021). This evidence concerns the gene CEACAM5 and ovarian cancer.